Sushma Saksena

4.2k total citations · 1 hit paper
22 papers, 2.6k citations indexed

About

Sushma Saksena is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Sushma Saksena has authored 22 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 15 papers in Hepatology and 8 papers in Surgery. Recurrent topics in Sushma Saksena's work include Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (12 papers) and Organ Transplantation Techniques and Outcomes (3 papers). Sushma Saksena is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (12 papers) and Organ Transplantation Techniques and Outcomes (3 papers). Sushma Saksena collaborates with scholars based in United Kingdom, India and United States. Sushma Saksena's co-authors include Alastair D. Burt, Giulio Marchesini, Keith D. Lindor, Marco Lenzi, Jason M. Hui, Christopher P. Day, Geoffrey C. Farrell, Schuyler O. Sanderson, Jacob George and Felicity Enders and has published in prestigious journals such as Hepatology, Gut and Journal of Hepatology.

In The Last Decade

Sushma Saksena

22 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The NAFLD fibrosis score

2007 2.3k citations Paul Angulo, Jason M. Hui et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sushma Saksena United Kingdom	10	2.4k	1.5k	866	495	365	22	2.6k
Dev Samarasinghe Australia	14	2.0k 0.8×	1.0k 0.7×	706 0.8×	339 0.7×	248 0.7×	22	2.3k
Sherif Saadeh United States	10	2.0k 0.8×	1.1k 0.7×	784 0.9×	370 0.7×	333 0.9×	11	2.2k
Terry Gramlich United States	14	3.1k 1.3×	1.5k 1.0×	1.4k 1.6×	541 1.1×	631 1.7×	22	3.5k
Sanne Dam‐Larsen Denmark	9	2.7k 1.1×	1.5k 1.0×	1.1k 1.2×	391 0.8×	492 1.3×	15	2.9k
Nila Rafiq United States	16	2.8k 1.2×	1.4k 0.9×	1.3k 1.5×	491 1.0×	554 1.5×	26	3.1k
Elsbeth Henderson United Kingdom	9	1.9k 0.8×	1.0k 0.7×	769 0.9×	265 0.5×	353 1.0×	12	2.1k
Svanhildur Hafliðadóttir Norway	6	2.6k 1.1×	1.6k 1.1×	905 1.0×	364 0.7×	388 1.1×	8	2.7k
Miguel Carneiro de Moura Portugal	21	2.0k 0.8×	1.1k 0.7×	680 0.8×	295 0.6×	367 1.0×	73	2.6k
Kittichai Promrat United States	16	2.4k 1.0×	1.2k 0.8×	1.1k 1.3×	340 0.7×	311 0.9×	34	2.8k
Janet C. Shaw United States	7	1.9k 0.8×	825 0.6×	855 1.0×	496 1.0×	338 0.9×	9	2.4k

Countries citing papers authored by Sushma Saksena

Since Specialization

Citations

This map shows the geographic impact of Sushma Saksena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sushma Saksena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sushma Saksena more than expected).

Fields of papers citing papers by Sushma Saksena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sushma Saksena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sushma Saksena. The network helps show where Sushma Saksena may publish in the future.

Co-authorship network of co-authors of Sushma Saksena

This figure shows the co-authorship network connecting the top 25 collaborators of Sushma Saksena. A scholar is included among the top collaborators of Sushma Saksena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sushma Saksena. Sushma Saksena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Verma, Sumita, et al.. (2024). Effective palliation of refractory ascites in cirrhosis is challenging. International Journal of Palliative Nursing. 30(6). 286–293. 1 indexed citations

Verma, Sumita, et al.. (2021). P169 Long term abdominal drain for palliation in advance liver cirrhosis: survey of risks & barriers. A130.2–A131. 1 indexed citations

Mitchison, Hannah M., Sushma Saksena, & Mark Hudson. (2018). Ncepod and Alcohol-Related Liver Disease, What are the Views of those who Deliver the Service? A Survey of Consultants and Trainees in North Eastern England. The Journal of the Royal College of Physicians of Edinburgh. 48(4). 293–298. 1 indexed citations

Hudson, Mark, Amr Radwan, Paola Maggio, et al.. (2017). The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS). Frontline Gastroenterology. 8(4). 243–251. 21 indexed citations

Martin, Natasha K., Peter Vickerman, Alec Miners, et al.. (2016). Is increased hepatitis C virus case‐finding combined with current or 8‐week to 12‐week direct‐acting antiviral therapy cost‐effective in UK prisons? A prevention benefit analysis. Hepatology. 63(6). 1796–1808. 50 indexed citations

Orr, James, et al.. (2013). PTU-112 Rifaximin for Hepatic Encephalopathy is Cost Effective at Reducing Emergency Hospital Admission. Gut. 62(Suppl 1). A91.3–A92. 2 indexed citations

Saksena, Sushma, et al.. (2007). Induction of hepatic 11β‐hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease. Clinical Endocrinology. 68(6). 898–903. 16 indexed citations

Angulo, Paul, Jason M. Hui, Giulio Marchesini, et al.. (2007). The NAFLD fibrosis score. Hepatology. 45(4). 846–854. 2343 indexed citations breakdown →

Day, Chris, et al.. (2002). Genetic evidence supporting the two-hit model of NASH pathogenesis. Hepatology. 4 indexed citations

10.

Garcia, Raquel Francine Liermann, et al.. (2001). Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation. Arquivos de Gastroenterologia. 38(4). 247–253. 7 indexed citations

11.

Milkiewicz, Piotr, et al.. (2000). Plasma elimination of cholyl‐lysyl‐fluorescein (CLF): a pilot study in patients with liver cirrhosis. Liver International. 20(4). 330–334. 15 indexed citations

12.

Milkiewicz, Piotr, Sushma Saksena, Stefan G. Hübscher, & Elwyn Elias. (2000). Wilson’s disease with superimposed autoimmune features: Report of two cases and review. Journal of Gastroenterology and Hepatology. 15(5). 570–574. 60 indexed citations

13.

Milkiewicz, Piotr, Bridget Gunson, Sushma Saksena, et al.. (2000). INCREASED INCIDENCE OF CHRONIC REJECTION IN ADULT PATIENTS TRANSPLANTED FOR AUTOIMMUNE HEPATITIS: ASSESSMENT OF RISK FACTORS1. Transplantation. 70(3). 477–480. 40 indexed citations

14.

Saksena, Sushma, et al.. (2000). Evaluation of endoscopy-based diagnostic methods for the detection of Helicobacter pylori.. PubMed. 19(2). 61–3. 7 indexed citations

15.

Morales, Enrique, Raquel Francine Liermann Garcia, Sushma Saksena, S.G. Hübscher, & E. Elias. (2000). Recurrrent and de novo non-alcoholic steatohepatitis (NASH)following orthotopic liver transplantation (OLT). Journal of Hepatology. 32. 57–57. 3 indexed citations

16.

Milkiewicz, Piotr, et al.. (1998). Cholyl lysylfluorescein (CLF) plasma clearance in patients with liver diseases: a new dynamic liver function test?. Journal of Hepatology. 28. 77–77. 1 indexed citations

17.

Saksena, Sushma & Elwyn Elias. (1997). Transjugular intrahepatic portosystemic shunting (TIPS): a shunt is a shunt is a shunt!. European Journal of Gastroenterology & Hepatology. 9(1). 3–5. 13 indexed citations

18.

Sharma, Malvika, Srinivasan Dasarathy, Shubham Misra, Sushma Saksena, & K. R. Sundaram. (1996). Sonographic signs in portal hypertension: a multivariate analysis.. PubMed. 17(2). 23–9. 3 indexed citations

19.

Bhargava, D. K., Srinivasan Dasarathy, & Sushma Saksena. (1995). Long‐Term Management of Esophageal Varices by Endoscopic Sclerotherapy (EST): A Review of 12 Years′ Experience. Diagnostic and therapeutic endoscopy. 2(4). 211–217. 1 indexed citations

20.

Acharya, Subrat Kumar, Srinivasan Dasarathy, Sushma Saksena, & J N Pande. (1993). A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. Journal of Hepatology. 19(2). 291–300. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact